Status | Study |
Terminated |
Study Name: A Phase 1 Study of LJPC-501 in Patients With Hepatorenal Syndrome Condition: Hepatorenal Syndrome Type I and Type II Date: 2013-07-17 Interventions: Drug: LJPC-501 Patients will receive LJPC-501 at titrated doses, with a starting range from 1 to 100 ng/ |
Completed |
Study Name: Plasma and Hemodynamic Markers During Hepatectomy Condition: Hepatorenal Syndrome, Liver Regeneration Date: 2012-10-02 Interventions: Procedure: Liver resection Liver resection of patient with neoplastic hepatic tumors |
Withdrawn |
Study Name: To Compare the Efficacy of Nor Adrenaline and Terlipressin vs Step up Terlipressin Therapy in Hepatorenal Syndrome Condition: Hepatorenal Syndrome Date: 2012-07-21 Interventions: Drug: nor adrenaline and terlipressin |
Completed |
Study Name: TYPE 2 HEPATORENAL SYNDROME Condition: Safety and Efficacy of Terlipressin and Noradrenaline and Predictive Factors of Response in Type 2 HRS Date: 2012-06-28 Interventions: Drug: Noradrenaline Patients i |
Recruiting |
Study Name: Midodrine, Octreotide and Albumin: Impact on Renal Function of Patients With Liver Cirrhosis and Renal Failure Condition: Fibrosis Renal Failure Hepatorenal S Date: 2012-04-27 Interventions: Drug: Albumin Albumin (20%) 1g |
Active, not recruiting |
Study Name: Treatment of Hepatorenal Syndrome With Terlipressin Infusion Adjusted to Hemodynamic Response Condition: Cirrhosis Hepatorenal Syndrome Type I Date: 2012-02-09 Interventions: Drug: Terlipressin and albumin Terlipressin dose: 2mg/24h, |
Completed |
Study Name: Safety and Pharmacokinetics of Ifetroban in Hepatorenal Syndrome Patients Condition: Hepatorenal Syndrome Date: 2011-08-31 Interventions: Drug: Ifetroban Injection Ifet |
Completed |
Study Name: A Study of Terlipressin in Patients With Hepatorenal Syndrome Type 1 Condition: Hepatorenal Syndrome Type 1 Date: 2011-06-10 Interventions: Drug: Terlipressin |
Completed |
Study Name: A Placebo-Controlled, Double-Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 With Terlipressin Condition: HRS Date: 2010-06-11 Interventions: Drug: Terlipressin Blinded ter |
Terminated |
Study Name: Terlipressin + Albumin Versus Midodrine + Octreotide in the Treatment of Hepatorenal Syndrome Condition: Cirrhosis Hepatorenal Syndrome Date: 2008-08-26 Interventions: Drug: Terlipressin plus albumin |